Search Results - "MCCARY, Laura C"

Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus by Zella, Julia B, McCary, Laura C, DeLuca, Hector F

“…1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), the biologically active form of vitamin D, is widely recognized as a modulator of the immune system as well as a…”
Get full text

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease by QUARLES, L. Darryl, SHERRARD, Donald J, ADLER, Stephen, ROSANSKY, Steven J, MCCARY, Laura C, WEI LIU, TURNER, Stewart A, BUSHINSKY, David A

“…Current treatment of secondary hyperparathyroidism in chronic kidney failure with calcium and active vitamin D is potentially limited by hypercalcemia and…”
Get full text

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis by Block, Geoffrey A, Martin, Kevin J, de Francisco, Angel L.M, Turner, Stewart A, Avram, Morrell M, Suranyi, Michael G, Hercz, Gavril, Cunningham, John, Abu-Alfa, Ali K, Messa, Piergiorgio, Coyne, Daniel W, Locatelli, Francesco, Cohen, Raphael M, Evenepoel, Pieter, Moe, Sharon M, Fournier, Albert, Braun, Johann, McCary, Laura C, Zani, Valter J, Olson, Kurt A, Drüeke, Tilman B, Goodman, William G

“…Hypercalcemia and hyperphosphatemia often complicate secondary hyperparathyroidism therapy in patients who are receiving dialysis. Unlike vitamin D and…”
Get full text

The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism by Shoback, Dolores M., Bilezikian, John P., Turner, Stewart A., McCary, Laura C., Guo, Matthew D., Peacock, Munro

“…Calcimimetics increase the sensitivity of the calcium-sensing receptor (CaR) to circulating serum calcium, reducing the secretion of PTH and the serum calcium…”
Get full text

Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl by Moe, Sharon M., Chertow, Glenn M., Coburn, Jack W., Quarles, L. Darryl, Goodman, William G., Block, Geoffrey A., DrEke, Tilman B., Cunningham, John, Sherrard, Donald J., Mccary, Laura C., Olson, Kurt A., Turner, Stewart A., Martin, Kevin J.

“…Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl. The National Kidney Foundation's Kidney Disease Outcomes Quality…”
Get full text

Cinacalcet Hydrochloride Is an Effective Treatment for Secondary Hyperparathyroidism in Patients With CKD Not Receiving Dialysis by Charytan, Chaim, Coburn, Jack W., Chonchol, Michel, Herman, James, Lien, Y. Howard, Liu, Wei, Klassen, Preston S., McCary, Laura C., Pichette, Vincent

“…Background: Secondary hyperparathyroidism develops early in patients with chronic kidney disease (CKD). Clinical guidelines from the National Kidney…”
Get full text

First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl by Martin, Kevin J., Juppner, Harald, Sherrard, Donald J., Goodman, William G., Kaplan, Mark R., Nassar, George, Campbell, Patricia, Curzi, Mario, Harytan, Chaim C., Mccary, Laura C., Guo, Matthew D., Turner, Stewart A., Bushinsky, David A.

“…First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. First-generation immunometric assays for…”
Get full text

Oral administration of 1,25-dihydroxyvitamin D 3 completely protects NOD mice from insulin-dependent diabetes mellitus by Zella, Julia B, McCary, Laura C, DeLuca, Hector F

“…1,25-Dihydroxyvitamin D 3 (1,25(OH) 2D 3), the biologically active form of vitamin D, is widely recognized as a modulator of the immune system as well as a…”
Get full text

TECHNICAL NOTE: Achieving NKF-K-DOQI registered bone metabolism and disease treatment goals with cinacalcet HCl by Moe, Sharon M, Chertow, Glenn M, Coburn, Jack W, Quarles, LDarryl, Goodman, William G, Block, Geoffrey A, Drueeke, Tilman B, Cunningham, John, Sherrard, Donald J, McCary, Laura C, Olson, Kurt A, Turner, Stewart A, Martin, Kevin J

“…Background. The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (NKF-K-DOQI registered ) has established guidelines for treatment of…”
Get full text

A Characterization of Vitamin D-Independent Intestinal Calcium Absorption in the Osteopetrotic (op/op) Mouse by McCary, Laura C., Staun, Michael, DeLuca, Hector F.

“…Previous work in our laboratory showed that the osteopetrotic (op/op) mouse possesses a vitamin D-independent mechanism of intestinal calcium absorption. This…”
Get full text

Osteopetrotic (op/op) mice are unable to maintain serum calcium levels despite hyperabsorption of calcium by McCary, L C, DeLuca, H F

“…The effect of vitamin D on serum calcium, vitamin D receptor (VDR) protein level, and fate of radioactive calcium ingested were compared in vitamin D-deficient…”
Get full text

Hypophosphatemia and the Development of Rickets in Osteopetrotic (op/op) Mice by Mccary, Laura C., Smith, Connie M., Deluca, Hector F.

“…Our previous work has shown that op/op mice hyperabsorb dietary calcium in the vitamin D–deficient state and shunt that calcium into bone. Under these…”
Get full text